You are here

Electronic Tablets Speed Stroke Care During Patient Transport, Study Finds

Neurologists could remotely assess stroke while patients were en route

A clinical trial testing mobile videoconferencing as a means for physicians to diagnose stroke patients while they're being transported to the hospital has found that a tablet-based system produced diagnoses highly correlating with a bedside assessment—a finding that could have important implications for the early treatment of stroke and for preventing the disability it causes.

The Improving Treatment with Rapid Evaluation of Acute Stroke via Mobile Telemedicine (iTREAT) study used a low-cost, tablet-based system that allows physicians to be in the ambulance, virtually, with patients who are being transported. The iTREAT kit contains a tablet suction-mounted to the wall of an ambulance, a portable modem, and antenna, which allow an encrypted form of video consultation between a neurologist and the stroke patient, as well as with the emergency medical service (EMS) provider.

"In our initial feasibility testing, we partnered with rural ambulance agencies to allow enough time for the stroke assessment and tested our mobile telestroke system in simulated stroke scenarios," explained Andrew Southerland, MD, the head of the University of Virginia Health System team that conducted the study.

The study found that more than 90% of the test runs conducted locally had sufficient quality and audiovisual connectivity to perform the consultation. The researchers determined that stroke testing results were 98% correlated with assessments that would have been done at the bedside. In other words, iTREAT was just as accurate as a bedside assessment by a neurologist, which would allow for better transport decisions by the EMS team and potentially faster treatment of the patient once at the hospital.

The standard neurological screening exam in a stroke evaluation is the National Institutes of Health's Stroke Scale, performed by neurologists and emergency medicine physicians. The ability to have a neurologist assess the patient extensively during the trip to the hospital could help save time in assessing the patient once at the hospital, and would inform important transport decisions such as whether the patient should be brought to a tertiary center for specialized care or simply taken to the nearest hospital.

"Acute stroke is a very time-dependent illness," Southerland explained. "Specifically, in acute ischemic stroke, if you can remove the vascular obstruction and revascularize the injured part of the brain in a timely way, you can potentially prevent disability and death."

The treatment of ischemic stroke, the most common type of stroke, is a clot-busting medication and/or endovascular procedure that can resolve the obstruction in the artery that is preventing blood flow to the brain. But these treatments must be administered as quickly as possible within a few hours after the onset of the stroke. Many stroke patients do not arrive at the hospital quickly enough to receive beneficial treatment, so the ability to earlier identify a stroke is crucial for better treating stroke patients.

"The goal of our study is to advance the assessment of acute stroke to the prehospital setting—to the ambulance transporting the patients to the hospital," Southerland said.

The study results have been published by the scientific journal Neurology.

Continuing their research, Southerland and his team are conducting a trial enrolling real stroke patients, with the goal of eventually implementing a study across the nation in a multicenter clinical trial.

Source: EurekAlert; July 1, 2016.

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs